The potential position and

angulation of the implants are

The potential position and

angulation of the implants are measured relative to the metal plates using the CT data. The radiographic template is converted into a surgical template by attaching rigid metal rods that guide the handpiece precisely during subsequent drilling procedures. “
“Fractures involving pediatric jaws most often require a splint to prevent the fragments from being displaced; however, impression making presents a challenge. This article describes the fabrication of a surgical splint over an ideal cast, which is subsequently refitted with a tissue conditioner onto the patient’s jaw. The highlight of this technique is the elimination of an impression procedure, thereby reducing clinical and laboratory time and easing pain in the child. “
“Prostheses may be attached to implants or implant abutments using screw retention or cementation. With the increased use of cement-retained, implant-supported restorations for the replacement of missing teeth, clinicians may choose to use a definitive cement to lute the definitive restoration. Loosening of an abutment screw is a challenging complication of cement-retained, implant-supported prosthetic restorations. Often, the abutment screw becomes

loose from the implant body, whereas the crown remains cemented to the abutment. In such situations, separating the cemented crown from the underlying abutment or locating the abutment-screw access for removal of the Mirabegron restoration is a Lenvatinib nmr difficult task. The purpose of this report is to describe a simple technique for locating the abutment-screw access in the event

of its loosening. The advantage of this technique is that it can facilitate easy location of the abutment screw, thus minimizing damage to the existing restoration and allowing it to be reused. “
“This article is an overview of the biomechanics and advantages of telescopic retainers. Telescopic retainers offer more possibilities than any other treatment modality available in modern dentistry. Telescopic implant fixtures make the already versatile technique even more flexible. Telescopes should not be forgotten as a treatment modality, but should be embraced as a great option. “
“Implant-retained overdentures have been shown to be a predictable, accepted option and represent a viable and cost-effective treatment; however, patients with severe lack of bone volume and anatomical limitations are often a contraindication to the placement of osseointegrated implants without prior surgical procedures. In these situations, the placement of angled implants may offer a simple solution. This clinical report describes a case of dental rehabilitation using angled implants for a patient with a severely resorbed edentulous maxilla. The inclination has been solved by making a bar on the right side and individual pillars on the left side so as to obtain a functional and esthetic prosthetic result.

The 100-mg cyclosporine dose and the 2-mg tacrolimus dose were ch

The 100-mg cyclosporine dose and the 2-mg tacrolimus dose were chosen as they were well tolerated in healthy volunteers in previous studies.23, 24 The doses of cyclosporine and tacrolimus were lowered when coadministered with telaprevir because of the potential for marked increase in cyclosporine and tacrolimus exposure. Dose-normalized cyclosporine exposure increased significantly when coadministered with telaprevir compared to administration of cyclosporine alone: the dose-normalized Cmax increased by approximately 1.3- to 1.4-fold, dose-normalized AUC increased by approximately 4.1- to 4.6-fold, and mean t½ of cyclosporine

increased approximately 4-fold following coadministration

of cyclosporine with either a single dose or steady-state telaprevir. Cyclosporine exposure Acalabrutinib cell line was comparable when administered with either a single dose of telaprevir (day 1, period 2) or when telaprevir reached steady-state (day 8, period 2), suggesting an absence of time-dependent inhibition of cyclosporine metabolism by telaprevir. The effect of telaprevir coadministration was much greater with tacrolimus: the dose-normalized Cmax increased by approximately 9.3-fold, dose-normalized AUC increased by approximately 70-fold, and the mean t½ of tacrolimus increased approximately 5-fold. Because of the long t½ of tacrolimus and the long time it STA-9090 cell line would take to wash out any effect of telaprevir on its PK, the interaction with tacrolimus was only evaluated with steady-state telaprevir. It is unknown whether the magnitude of the effect of telaprevir on tacrolimus would be similar after the first dose of telaprevir, as seen with cyclosporine. These results are significant and ifenprodil indicate that without understanding the adjustments required for dose

and/or dosing frequency of cyclosporine and tacrolimus, telaprevir coadministration could lead to serious or life-threatening adverse events. The mechanism for the greater effect of telaprevir on the PK of tacrolimus compared to cyclosporine is unknown, but may be related to lower bioavailability of tacrolimus (≈18%) in healthy volunteers,19 making it more susceptible to CYP3A and/or P-gp inhibition in the gut and during first-pass metabolism. This is also suggested by the 9.3-fold increase in the tacrolimus Cmax and the sharp decrease in the mean (SD) apparent volume of distribution (Vz/F) of tacrolimus from 1,910 (859) L when administered alone to 106 (34) L (Table 2) in the presence of telaprevir (i.e., an increase in oral bioavailability, F, without a proportional change in volume of distribution, Vz, may decrease the ratio, Vz/F closer to the reported value of Vz, corrected for F, in healthy volunteers of 1.94 L/kg19).

The HCV sequences of final maxipreps (Qiagen, Valencia, CA) were

The HCV sequences of final maxipreps (Qiagen, Valencia, CA) were confirmed (Macrogen Inc., Seoul, Korea). Culturing of Huh7.5 hepatoma cells was as described.[19] 24h before transfection or infection, 4 × 105 cells per well were plated in six-well plates (Nunc; Thermo Fisher Scientific Inc., Waltham, MA). Plasmids were linearized with XbaI, followed by in vitro transcription with T7 RNA polymerase (Promega, Madison, WI) for 2 hours at 37°C. For transfections, 2.5 μg of RNA were incubated with 5 μL of Lipofectamine 2000 in 500 HDAC inhibitor μL of OptiMEM (Invitrogen) for 20 minutes. Cells were incubated with RNA/Lipofectamine complexes

for 16-24 hours. For infections, cells were inoculated with filtered virus-containing

culture supernatant for 16-24 hours. Cultures were evaluated by immunostaining with NS5A Ab 9E10.[19] HCV RNA titers were determined by TaqMan.[19] HCV infectivity titers were determined by adding 10-fold dilutions (starting at 1:2) of supernatants, in triplicate, into 6 × 103 Huh7.5 cells/well of poly-D-lysine-coated 96-well plates (Nunc; Thermo Fisher Scientific). After 48-hour incubation, cells were fixed and immunostained with 9E10 Ab. The number of focus-forming units (ffu) was determined Tamoxifen solubility dmso using an ImmunoSpot series 5 UV analyzer (CTL Europe GmbH, Bonn, Germany).[17, 21, 28] Procedures to generate amplicons for direct sequencing of the complete open reading frame (ORF) and primers for the JFH1 portion were previously reported[19]; Core-NS2-specific

primers are shown in Supporting Table 1. Sequences were analyzed using Sequencher (Gene Codes) and Vector NTI (Invitrogen). Phylogenetic trees were generated using the Jukes-Cantor model and the Neighbor-joining algorithm implemented by Molecular Evolutionary Genetics Analysis (MEGA) software. We analyzed two panels of chronic-phase sera Acesulfame Potassium from HCV genotype 2 patients originating from the Hospital Clinic (Barcelona, Spain) and the National Institutes of Health (Bethesda, MD). All patients were presumably HCV monoexposed, according to clinical records. The genotype and subtype of the infecting HCV was determined by direct sequencing of Core-E1 amplicons[29]; analysis of sample K1118 required cloning of the amplicon. For phylogenetic analysis, we used MEGA. Heat-inactivated (56°C for 30 minutes) patient sera were tested in 2-fold dilutions against J6/JFH1, T9/JFH1, DH8/JFH1, DH10/JFH1, J8/JFH1, and S83/JFH1 and in 5-fold dilutions against J6/JFH1ΔHVR1 and J8/JFH1ΔHVR1.[16] Polyclonal immunoglobulin G (IgG) was purified from 100 μL of serum from four selected samples, using a Protein G HP SpinTrap/Ab Spin Trap system (GE Healthcare, Little Chalfont, UK), and tested against J6/JFH1 and J6/JFH1ΔHVR1 in 5-fold dilutions starting at 100 μg/mL.

Patients and Methods: One hundred and seventy four treatment-naTv

Patients and Methods: One hundred and seventy four treatment-naTve HBeAg-positive CHB patients had been treated with ETV for at least 1 year. Serum HBsAg was measured with the Abbott Architect HBsAg QT assay. The qHBsAg levels were determined at baseline, at the time of HBeAg loss and/or seroconversion, and then annually after HBeAg loss. Additional therapy following HBeAg loss was defined as consolidation therapy in the current study. Results: During the mean treatment duration of 51 ±21 months, 90 out of 174 patients (51.7%) achieved HBeAg loss and selleck compound 51 patients

(29.3%) achieved HBeAg seroconversion. Twenty-six patients achieved HBeAg loss and seroconversion concurrently and 25 patients achieved Daporinad molecular weight HBeAg seroconversion with a median interval of 3.0±11.5 (0.75-47) months following HBeAg loss. The mean treatment duration and the mean time

to HBeAg loss for the 90 patients was 51.2±19.4 and 25.1 ±20.1 months, respectively. Seventy three (81.1%), 27 (30%), 12 (13.3%), 7 (7.9%), and 4 (4.4%) patients had received 1, 2, 3, 4, and 5 years of consolidation therapy following HBeAg loss, respectively. The median qHBsAg decline from HBeAg loss to HBeAg seroconversion in the 25 patients was 0.0±0.06 log10 IU/ mL. Among 73 patients with at least one year of consolidation therapy, the median decline in qHBsAg levels from baseline to HBeAg loss, and from HBeAg loss to one year after HBeAg loss were 0.36±0.80 (P<0.0001) and 0.00±0.23 (P=0.7304) log10 IU/mL, respectively. Among 27 patients with at least two years of consolidation therapy, the median decline in qHB-sAg levels from baseline to HBeAg loss, from HBeAg loss to one year after HBeAg loss, and from one year to two years after HBeAg loss were 0.27±0.57 (P=0.0017),

0.04±0.37 (P=0.9896), and 0.10±0.26 log10 IU/mL (P=0.009), respectively. Among 12 patients with at least three years of consolidation Methane monooxygenase therapy, the median decline in qHBsAg levels from baseline to HBeAg loss, from HBeAg loss to one year after HBeAg loss, from one year to two years, and from two years to three years after HBeAg loss were 0.41 ±0.49 (P=0.0244), 0.01 ±0.44 (P=0.9697), 0.10±0.31 (P=0.0273), and 0.08±0.21 log10 IU/mL (P=0.0137), respectively. Conclusion: Long-term ETV therapy is associated with a significant qHBsAg decline from baseline to HBeAg loss, and during the second and third, but not the first year of consolidation therapy following HBeAg loss in HBeAg-positive CHB patients.

Further research into the role of obesity-related neuroendocrine

Further research into the role of obesity-related neuroendocrine peptides and neurotransmitters, their receptors and biochemical-signaling pathways may help elucidate migraine disease mechanisms and may initiate new preventive strategies. Acknowledgments: The authors would like to thank Ann Scher for her helpful comments and suggestions. (a)  Conception and Design (a)  Drafting the Manuscript (a)  Final Approval of the Completed Manuscript

“Purpose: The aims of this study were to: (1) investigate the perceptions and experiences of predoctoral dental students and advanced standing students on mentorship, exposure to prosthodontics, and future need for the specialty, and (2) establish a baseline of students’ Erismodegib solubility dmso perceptions of the NVP-BEZ235 impact of prosthodontics on salary, personal and patient quality of life, and the profession of dentistry. Materials and Methods: A survey was distributed to 494 predoctoral and

advanced standing students at the University of Pennsylvania School of Dental Medicine. Questions focused on the perceptions and experiences with the specialty of prosthodontics. A total of 410 surveys were analyzed using Chi Square tests and univariate and multivariate analysis with statistical software. Results: Response rate was 83%. A positive initial introduction to prosthodontics

was reported by 57% of students. Most students had positive experiences with prosthodontic faculty and enjoyed laboratory work and challenging/complex dentistry. A greater need for prosthodontists in the future was perceived by 82% of respondents, with 63% reporting that the future of prosthodontics had been emphasized. Students reported (1) a preclinical course directed by prosthodontists and (2) working in the clinic with prosthodontic faculty (p < 0.006) as having the biggest impact on their introduction to prosthodontics. A desire to pursue training or a career in prosthodontics was reported by 3.4% of the respondents, with 1.7% of them pursuing prosthodontics. Dynein Enjoyment of providing care in prosthodontics was the most important factor for those who decided to pursue prosthodontic postgraduate training. When compared to other specialties, prosthodontics ranked low with regards to its impact on salary (7th), personal quality of life (5th), patient quality of life (4th), and strengthening of the dental field (7th). Conclusion: Reasons few students are interested in prosthodontics as a career, despite a positive first introduction and high perceived future need for prosthodontists may be attributed to a number of factors.

This study compared the microleakage of teeth restored with nine

This study compared the microleakage of teeth restored with nine frequently used commercial dowel systems in vitro. There were significant differences between the FRC dowels and the stainless steel dowels, and even among the FRC dowel groups. As such, the hypothesis tested, which stated there are no significant differences in microleakage between teeth restored with FRC dowels and those restored with stainless

steel dowels, is rejected. Similarly, Usumez et al reported better relative microleakage results for glass and polyethylene fiber-reinforced dowel groups than for metallic and zirconia dowel groups.[14] The literature reports various leakage measurement methods, such as dye or tracer molecule penetration measurement, evaluation of bacterial penetration, spectrometry of radioisotopes, gas chromatography, and fluid filtration, but there is no consensus on the reliability and precision of these methods. The fluid filtration method was first described by Derkson et al[16] and then modified and used by

Pashley et al[17] to evaluate the leakage of temporary filling materials. With this method, quantitative rather than qualitative results could be obtained, and the method allows the researcher to make repeated measurements at different time intervals owing to the nondestructive design of the method. It is reported that the presence of trapped air and fluids in the microgaps at the bonding interface negatively affects the penetration

and diffusion of dyes, tracer molecules, bacteria, or ions when using the penetration evaluation methods.[18, 19] The PAK5 use of positively pressurized water in the fluid filtration method ensures that these kinds of difficulties are overcome.[20] Several authors reported that fluid filtration method is a more reliable and precise method than penetration measurement methods.[20, 21] As mentioned before, one of the goals of a dowel application is to reseal the prepared root canal by a proper dowel cementation process to avoid microleakage of bacteria and bacterial byproducts.[3] However, none of the dowel systems tested in this study provided an absolute seal. The percentage of the relative microleakage of pressurized water through the root canal ranged from 3.55 × 10−4% to approximately two times higher (7.06 × 10−4%) among the different groups. Test parameters in the current study were designed to standardize the resin cement and root canal surface conditioning procedures; therefore, it must be considered that differences in microleakage among the groups originated from microleakage through the dowel/cement interface.

2, 4) Of note, loss of TRRAP was accompanied by a dramatic loss

2, 4). Of note, loss of TRRAP was accompanied by a dramatic loss of both c-Myc and E2F1 binding at the

cycin A promoter (Fig. 5D-F), suggesting that TRRAP and/or HAT-mediated acetylation play an important role Dabrafenib price in the recruitment of these transcription factors to the cyclin promoters in regenerating livers. Our results demonstrate that TRRAP and HATs play a critical role in liver regeneration through their function in cell cycle reentry and proliferation of quiescent hepatocytes following liver damage. After CCl4treatment, TRRAP-deficient mice revealed impaired liver regeneration without alteration of the degree of initial histologic injury, indicating that TRRAP is needed for regeneration of damaged liver tissue. TRRAP-deficient hepatocytes exhibited a dramatic PD0332991 in vitro proliferation defect as seen by the dramatic reduction in both BrdU- and PCNA-positive cells in TRRAP-deficient livers after CCl4 treatment. These findings show that TRRAP is essential for cell cycle entry of hepatocytes after liver injury and that the reduced viability of TRRAP-deficient

mice treated with CCl4 may be caused by the hepatocytes’ failure to regenerate the injured liver. However, the possibility that loss of TRRAP may affect other liver functions, which may contribute to the phenotype of TRRAP-deficient mice, could not be formally ruled out. The observation that TRRAP-CKO livers after CCl4 treatment did show an increase in hepatocyte proliferation, although more severely attenuated than that seen in TRRAP-containing livers, may be explained by the presence of the remaining TRRAP protein in a fraction of the hepatocytes (“escapers of deletion”), which may be sufficient to support cell cycle entry. However, TRRAP protein levels may be further diluted during cell cycle progression. In support of this is the frequent appearance of mitotic

errors in TRRAP-deficient livers, a finding that is consistent with the role of TRRAP in mitotic progression.10, 13 Together with previous findings on TRRAP-deficient cells,13 our results show that TRRAP plays a key role during entry into and progression through the cell cycle (including mitosis) owing to its association with different transcription OSBPL9 factors and expression of distinct sets of cell cycle-specific genes (Supporting Fig. 2A). However, the mechanism by which TRRAP mediates hepatocyte regeneration may involve other layers of regulation (including posttranslational modifications of key cell cycle players). Of note, we found that loss of TRRAP also compromised the proliferation of nonparenchymal cells, suggesting that TRRAP is important for cell cycle progression and proliferation of not only parenchymal cells (hepatocytes) but also of nonparenchymal cells during liver regeneration.

Ethanolamine oleate is inactivated immediately when it reaches th

Ethanolamine oleate is inactivated immediately when it reaches the serum by binding to albumin, so it is likely that in cirrhotic patients with low serum albumin a considerably higher amount of unbound ethanolamine oleate could reach the portal vein, thus directly affecting liver cells. Alternatively it may circulate forming micro thrombi in the portal system resulting in ischemic liver cell damages as reported by Nakagawa et al.18 Fewer treatment sessions were needed for eradication click here of varices in patients treated with endoscopic band

ligation versus sclerotherapy (3.7 ± 0.46 vs 6 ± 0.98), but band ligation has a high recurrence rate when compared with sclerotherapy. The recurrence rate of varices in this study was 14% in group I, and 28% in Group II and this difference was found to be statistically significant. Our results were in accordance with those reported by Hou find more et al.19 who found that endoscopic variceal ligation is superior to sclerotherapy because of its lower rebleeding and complication rates. However, ligation is not without drawbacks due to a higher tendency to variceal recurrence. So, additional therapy

should be considered after endoscopic variceal ligation to decrease the recurrence rate.10 In this study the new method of scleroligation as described by Dhiman et al.20 was performed on 50 patients (Group III). In this study, only two scleroligation sessions were required to obtain

complete eradication of varices in 41 patients (82%), while three scleroligation sessions were required to obtain the same results in nine patients (18%). A marked reduction in variceal size was observed following the first endoscopic scleroligation in all patients during the first follow-up session. Recurrence of esophageal varices after obliteration was reported in only one patient (2%) during the follow-up period of 17.8 ± 4.85 months, and rebleeding didn’t occur in any patient belonging to the scleroligation group. In this study, the recorded satisfactory results with scleroligation were not found to be associated with any increase in the number of general complications and there were no specific local complications. Our results were found to be in accordance Docetaxel with those reported by Umehara et al.21 who studied 51 patients with cirrhosis and esophageal varices. These patients were randomly assigned to be treated either by endoscopic scleroligation (n = 25) or endoscopic variceal ligation (n = 26). They found that the cumulative recurrence rate in the endoscopic scleroligation group was 9.5%, which is significantly lower than that recorded for the endoscopic variceal ligation group (61.9%). They concluded that endoscopic scleroligation is superior to endoscopic variceal ligation in preventing variceal recurrence.

[402, 403] Absolute contraindications to LT are those clinical ci

[402, 403] Absolute contraindications to LT are those clinical circumstances that consistently lead to poor outcome for the patient and graft. Relative contraindications are those situations which may lead to poor patient and graft outcome, but are potentially correctable check details (Table 4). Given that the need for posttransplant immunosuppression inherently increases the risk of de novo and recurrent malignancy, most centers require some period of recurrence-free survival and a low projected rate of recurrence of primary malignancy before listing for LT.[404] Active, uncontrolled extrahepatic malignancy should be considered an absolute contraindication

to LT in children. Patients who have liver metastases from neuroendocrine tumors are a potential exception to this category, a situation rarely encountered LDK378 research buy in pediatrics.[405] Specific discussions regarding the evaluation of extrahepatic extension of

liver-based tumors in childhood are located in other sections of this guideline. 90. Active, uncontrolled extrahepatic malignancy is an absolute contraindication to LT in children. (1-A) Active uncontrolled infection from bacteria, fungus, or virus can lead to high postsurgical mortality and therefore LT in this situation is to be avoided.[402, 403, 406] Blood cultures and peritoneal fluid cultures (if applicable) should be negative for at least 48 hours prior to listing for transplant. Isolated case reports of successful LT in PALF associated with herpes simplex despite positive blood cultures have been

reported.[407, 408] 91. Active uncontrolled systemic infection from bacteria, fungus, or virus can lead to high postsurgical mortality, and therefore LT in this situation Bcl-w is to be avoided. (1-B) Niemann-Pick disease type C (NP-C) is a rare autosomal recessive systemic neuro-visceral disease characterized by progressive disabling neurological symptoms and premature death in most patients.[409] Clinical presentations of NP-C are heterogeneous and include cholestasis, hepatosplenomegaly, and acute liver failure.[409-412] Diagnosis requires demonstration of impaired intracellular cholesterol transport by filipin staining in fibroblasts cultured from patient skin biopsies. DNA sequencing should ideally be performed in parallel with filipin staining where possible, but cannot replace filipin staining as the primary diagnostic method.[409] Bone marrow infiltration with foam cells is a measure of disease burden, but may be minimal with early disease.[409] Histological features diagnostic of NP-C are found on liver biopsy in only 50% of cases.[413] LT has been shown to be ineffective in altering the progression of neurological deterioration.[414] 92. LT is contraindicated in NP-C as it does not alter neurological disease progression.

00 PM 143: The risk for hepatocellular carcinoma among patients w

00 PM 143: The risk for hepatocellular carcinoma among patients with chronic HCV infection and advanced hepatic fibrosis following sustained virological response Adriaan J. van der Meer, Jordan J. Feld, Harald Hofer, Piero L. Almasio, Vincenza Calvaruso, Conrado M. Fernandez-Rodriguez, Soo Aleman, Nathalie Ganne-Carrie, Roberta D’Ambrosio, Stanislas

Pol, Maria Trapero-Marugan, Ricardo Moreno-Otero, Vincent Mallet, Rolf W. Hultcrantz, Ola Weiland, Karoline Rutter, Vito Di Marco, Sonia Alonso, Savino Bruno, Massimo Colombo, Robert J. de Knegt, Bart J. Veldt, Bettina E. Hansen, Harry L. Janssen 4:15 PM 144: Sexual function is impaired in men and women with chronic hepatitis C Julien Vergniol, Genevieve

Hou, Juliette Foucher, Florence Chenus, Faberes Carole, Faiza Chermak, Aude Lafourniere, Noui Souakri, Victor de Ledinghen R428 Parallel 21: Inflammation and Fibrosis Monday, November 4 3:00 – 4:30 PM Room 150A MODERATORS: Natalie Torok, MD Robert Schwabe, MD 3:00 PM 145: HIV-infection of Kupffer cells results in a dysregulated response to LPS despite effective AntiRetroviral Therapy Arevik Mosoian, Feng find more Hong, Yedidya Saiman, Adeeb Rahman, Andrea D. Branch, Sasan Roayaie, Sander Florman, Francesc Cunyat, Mario Stevenson, Meena Bansal 3:15 PM 146: HCV is taken up by Flavopiridol (Alvocidib) human liver sinusoidal endothelial cells (LSECs) and triggers IFN Type I and III (lambda) production and autocrine/paracrine signaling that inhibits HCV replication Silvia Giugliano, Lucy Golden-Mason, Evgenia Dobrinskikh, Amy E. Stone, Alejandro Soto-Gutierrez, Michael Gale, Vijay Shah, Hugo R. Rosen 3:30 PM 147: Hepatic sdf-1 (CXCL12)

acts downstream of VEGF to recruit liver sinusoidal endothelial cell progenitor cells from the bone marrow in liver regeneration Laurie D. Deleve, Xiandong Wang, Lei Wang, William A. Gaarde 3:45 PM 148: Hepatic Stellate Cells Orchestrate Clearance of Dead Hepatocytes from the Liver after Acute Injury in a Hypoxia-inducible Factor-1α-dependent Manner Bryan Copple, Aaron Pace, Akie J. Mochizuki, Keara Towery, James P. Luyendyk 4:00 PM 149: Macrophage autophagy protects from liver fibrosis Jasper Lodder, Marie-Noële Chobert, Sophie Lotersztajn, Fatima Teixeira-Clerc 4:15 PM 150: The liver-derived plasma protein histidine-rich glycoprotein promotes chronic liver injury and fibrosis by polarizing hepatic macrophages towards the inflammatory M1 phenotype Matthias Bartneck, Viktor Fech, Josef Ehling, Xiao Wei, Klaudia Warzecha, Kanishka Hittatiya, Nikolaus Gassler, Twan Lammers, Willi Jahnen-Dechent, Christian Trautwein, Frank Tacke Parallel 22: Signaling in Hepatotoxicity Monday, November 4 3:00 – 4:30 PM Room 152A MODERATORS: Craig J. McClain, MD Urs A.